Association between white matter lesion and clinical symptoms in patients with Parkinson's disease

Du Jing, Wu Tieyu, Yan Sunhong, Xi Chunhua, Wang Kai

PDF(518 KB)
PDF(518 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (05) : 558-562. DOI: 10.13406/j.cnki.cyxb.003502
Treatment of movement disorders

Association between white matter lesion and clinical symptoms in patients with Parkinson's disease

Author information +
History +

Abstract

Objective To investigate the influence of cerebral white matter lesion（WML） on motor symptoms，cognitive function，and mood in patients with Parkinson's disease（PD）. Methods A total of 123 patients with PD who visited the Department of Neurology of the Second Affiliated Hospital of Anhui Medical University from January 2018 to December 2023 were included. Age‐related White Matter Changes（ARWMC） scale was used to evaluate the degree of cerebral WML on cranial MRI imaging，according to the score of the scale，the patients were divided into mild WML group with 46 patients and moderate‐to‐severe WML group with 77 patients. The Unified Parkinson's Disease Rating Scale Part Ⅲ（UPDRS‐Ⅲ） and Hoehn‐Yahr（H‐Y） Rating Scale were used to assess motor symptoms and disease severity； Mini‐Mental State Examination（MMSE） was used to assess cognitive function in PD； Hamilton Depression Scale and Hamilton Anxiety Scale were used to assess the emotion of PD patients； Barthel Index was used to assess the activities of daily living. The scores of motor symptoms，cognitive function，and mood in patients were compared between the two groups， and the relationship between WML and PD patients symptoms was analyzed by Logistic regression. Results The moderate‐to‐severe WML group had a significantly higher incidence rate of hypertension than the mild WML group（41.6% vs. 23.9%，P<0.05）. Compared with the mild WML group，the moderate‐to‐severe WML group had significantly higher H‐Y stage［2.5（1.5，3.0） vs. 2.0（1.5，2.5），P<0.05］ and UPDRS‐Ⅲ score（34.0±16.5 vs. 24.09±11.04，P<0.01）. Compared with the mild WML group，the moderate‐to‐severe WML group had significantly lower MMSE score［24.0（18.5，27.0） vs. 26.0（23.8，27.0），P<0.01］ and Barthel Index［（77.4±17.4） vs.（83.5±11.7），P<0.05］. The correlation analysis showed that total ARWMC score was positively correlated with H‐Y stage，UPDRS‐Ⅲ score，and age，while it was negatively correlated with MMSE score and Barthel Index. The logistic regression analysis showed a significant association between severe WML impairment and cognitive impairment（β=1.072，95% confidence interval：1.078~7.918，P=0.035）. Conclusion WML is associated with dyskinesia，cognitive impairment，and reduction in quality of life in PD.

Key words

Parkinson's disease / white matter lesion / dyskinesia / cognitive impairment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
Du Jing , Wu Tieyu , Yan Sunhong , et al . Association between white matter lesion and clinical symptoms in patients with Parkinson's disease. Journal of Chongqing Medical University. 2024, 49(05): 558-562 https://doi.org/10.13406/j.cnki.cyxb.003502

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis
1
Dorsey ER， Bloem BR. The parkinson pandemic-a call to action[J]. JAMA Neurol，2018，75（1）：9-10．
本文引用 [1]
2
Schmidt R， Ropele S， Enzinger C，et al. White matter lesion progression，brain atrophy，and cognitive decline：the Austrian stroke prevention study[J]. Ann Neurol，2005，58（4）：610-616．
本文引用 [1]
3
Lampe L， Kharabian-Masouleh S， Kynast J，et al. Lesion location matters：the relationships between white matter hyperintensities on cognition in the healthy elderly[J]. J Cereb Blood Flow Metab，2019，39（1）：36-43．
本文引用 [1]
4
Erten-Lyons D， Woltjer R， Kaye J，et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age[J]. Neurology，2013，81（11）：977-983．
本文引用 [1]
5
彭泽艳，董舒阳，周华东. 脑白质病变与老年帕金森病患者运动功能障碍的相关性研究[J]. 中华全科医学，2018，16（5）：693-696．
Peng ZY， Dong SY， Zhou HD. Association between white matter lesions and motor impairment in patients with Parkinson's disease[J]. Chin J Gen Pract，2018，16（5）：693-696．
本文引用 [1]
6
Ji GJ， Ren CP， Li Y，et al. Regional and network properties of white matter function in Parkinson's disease[J]. Hum Brain Mapp，2019，40（4）：1253-1263．
7
Scamarcia PG， Agosta F， Spinelli EG，et al. Longitudinal white matter damage evolution in Parkinson's disease[J]. Mov Disord，2022，37（2）：315-324．
本文引用 [1]
8
Herman T， Rosenberg-Katz K， Jacob Y，et al. White matter hyperintensities in Parkinson's disease：do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?[J]. PLoS One，2013，8（1）：e55193．
本文引用 [1]
9
de Schipper LJ， Hafkemeijer A， Bouts MJRJ，et al. Age- and disease-related cerebral white matter changes in patients with Parkinson's disease[J]. Neurobiol Aging，2019，80：203-209．
本文引用 [1]
10
Lane CA， Barnes J， Nicholas JM，et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort（Insight 46）：an epidemiological study[J]. Lancet Neurol，2019，18（10）：942-952．
本文引用 [1]
11
de Leeuw FE， de Groot JC， Oudkerk M，et al. Hypertension and cerebral white matter lesions in a prospective cohort study[J]. Brain，2002，125（Pt 4）：765-772．
本文引用 [1]
12
Petrea RE， Pinheiro A， Demissie S，et al. Hypertension trends and white matter brain injury in the offspring framingham heart study cohort[J]. Hypertension，2024，81（1）：87-95．
本文引用 [1]
13
Zhang BY， Wang YZ， Wang B，et al. MRI-based investigation of association between cerebrovascular structural alteration and white matter hyperintensity induced by high blood pressure[J]. J Magn Reson Imaging，2021，54（5）：1516-1526．
本文引用 [1]
14
Williams-Gray CH， Foltynie T， Brayne CE，et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort[J]. Brain，2007，130（Pt 7）：1787-1798．
本文引用 [1]
15
Schwartz RS， Halliday GM， Soh D，et al. Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease[J]. J Clin Neurosci，2018，58：70-74．
本文引用 [1]
16
Tsai HH， Tsai LK， Lo YL，et al. Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease[J]. Sci Rep，2021，11（1）：7115．
本文引用 [1]
17
Hou MM， Hou XJ， Qiu YQ，et al. Characteristics of cognitive impairment and their relationship with total cerebral small vascular disease score in Parkinson's disease[J]. Front Aging Neurosci，2022，14：884506．
本文引用 [1]
18
Zhang ZW， Li SS， Wang SM. Application of periventricular white matter hyperintensities combined with homocysteine into predicting mild cognitive impairment in Parkinson's disease[J]. Int J Gen Med，2023，16：785-792．
本文引用 [1]
19
Petrou M， Kotagal V， Bohnen NI. An update on brain imaging in parkinsonian dementia[J]. Imaging Med，2012，4（2）：201-213．
本文引用 [1]
20
王义精，高莉娜，郝淼淼，等. 帕金森病扩大的血管周围间隙增加及类淋巴系统功能障碍的机制研究[J]. 中国神经精神疾病杂志，2022，48（1）：21-27.
Wang YJ， Gao LN， Hao MM，et al. The enlarged perivascular space increased and the mechanism of dysfunction of glymphatic system in Parkinson disease[J]. Chin J Nerv Ment Dis，2022，48（1）：21-27．
本文引用 [1]
21
Rasmussen MK， Mestre H， Nedergaard M. The glymphatic pathway in neurological disorders[J]. Lancet Neurol，2018，17（11）：1016-1024．
本文引用 [1]
22
Moccia M， Tedeschi E， Ugga L，et al. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease[J]. J Neurol Sci，2016，367：215-219．
本文引用 [1]
23
Malek N， Lawton MA， Swallow DM，et al. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease[J]. Mov Disord，2016，31（10）：1518-1526．
本文引用 [1]
24
Jeong SH， Lee HS， Jung JH，et al. White matter hyperintensities，dopamine loss，and motor deficits in de novo Parkinson's disease[J]. Mov Disord，2021，36（6）：1411-1419．
本文引用 [1]
25
Chung SJ， Yoo HS， Shin NY，et al. Perivascular spaces in the basal Ganglia and long-term motor prognosis in newly diagnosed parkinson disease[J]. Neurology，2021，96（16）：e2121-e2131．
本文引用 [1]
26
Hall JM， Shine JM， Ehgoetz Martens KA，et al. Alterations in white matter network topology contribute to freezing of gait in Parkinson's disease[J]. J Neurol，2018，265（6）：1353-1364.
本文引用 [1]
27
Song IU， Kim YD， Cho HJ，et al.The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson's disease[J]. Parkinson's Relat Disord，2013，19（8）:761-763
本文引用 [1]
28
Carvalho de Abreu DC， Pieruccini-Faria F， Sarquis-Adamson Y，et al. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative[J]. Eur J Neurol，2023，30（4）：920-933.
本文引用 [1]

Comments

PDF(518 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Journal of Chongqing Medical University, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉